By Ken Dropkiewski The bioresorbable stent was approved for use by the FDA in July of 2016. The Absorb GT1 Bioresorbable Vascular Scaffold System, manufactured by Abbott, was all set to solve a litany of the problems inherent with conventional cardiac and vascular stents. Conventional stents, made of flexible metal […]
Author: Ken Dropiewski
Medical Groups Unite in Support of Science
NEWS PROVIDED BY American Society of Hematology 17 Apr, 2017, 08:38 ET WASHINGTON, April 17, 2017 /PRNewswire-USNewswire/ — As the world’s leading organizations representing clinicians, laboratory researchers, and physician-scientists committed to improving patient care, we support the March for Science and its nonpartisan call for the appreciation of scientific evidence, education, and investment. Science […]
Lombard Medical’s CEO Steps Down
OXFORDSHIRE, England–(BUSINESS WIRE)–Lombard Medical, Inc. (NASDAQ: EVAR), a developer, manufacturer and marketer of endovascular aortic aneurysm repair products, today announced that Simon Hubbert has stepped down from his position as CEO on April 18 after serving in the role for more than six years. A search is underway for a […]
Defibtech Names Robert Reinhardt As New CEO in Executive Shuffle
GUILFORD, Conn.–(BUSINESS WIRE)–Defibtech, LLC, a Nihon Kohden company based in Guilford, Conn., announced today that its board of directors has unanimously chosen Robert Reinhardt as Defibtech’s next chief executive officer. Reinhardt will succeed Gintaras Vaisnys, the company’s co-founder and current CEO, on April 11. Vaisnys will remain as an advisor […]
Lombard Medical and MicroPort Scientific Corporation Finalize Strategic Partnership Agreements
OXFORDSHIRE, U.K. & SHANGHAI–(BUSINESS WIRE)– Lombard Medical, Inc. (EVAR), a medical device company focused on endovascular aneurysm repair, and MicroPort Scientific Corporation (0853.HK), a leading global manufacturer and marketer of a diversified portfolio of medical devices, today announced the parties have finalized the definitive agreements to their strategic partnership first […]
Biotricity Files for its Second and Final FDA 510(k) to Bring Bioflux Solution to Market
REDWOOD CITY, Calif., April 12, 2017 (GLOBE NEWSWIRE) — Biotricity, Inc. (OTCQB:BTCY), a medical diagnostic and consumer healthcare technology company dedicated to delivering innovative, biometric remote monitoring solutions, has filed for a second and final 510(k) for the hardware portion of its Bioflux solution with the U.S. Food and Drug Administration […]
Coming to a Transplant Unit Near You: Drones Impact on the Delivery of Healthcare
BY KEN DROPIEWSKI The FAA predicts there will be 7 million drones registered in the US by 2020. While over half of the drones flying today belong to hobbyists, the rest are owned by private enterprise and various government agencies. However, despite their popularity, drones are a controversial tech. Opponents […]
First U.S. Patient Treated in Landmark Vascular Study of Lithoplasty® Technology
NEWS PROVIDED BY PinnacleHealth System | 05 Apr, 2017, 10:00 ET HARRISBURG, Pa., April 5, 2017 /PRNewswire/ — PinnacleHealth CardioVascular Institute enrolled the first patient in the United States in a trial assessing the safety and effectiveness of a new type of approach for blockages in the leg artery. DISRUPT PAD III is […]
Inari Medical Announces First Patient Treated with the ClotTriever™ Thrombectomy System
NEWS PROVIDED BY | Inari Medical Inc. | 10 Apr, 2017, 09:00 ET IRVINE, Calif., April 10, 2017 /PRNewswire/ — Inari Medical Inc., a venture capital backed medical device company focused on the interventional treatment of venous thrombus, announced the treatment of the first patient with its ClotTriever Thrombectomy System. The ClotTriever Thrombectomy System received […]
Zio by iRhythm Gains Further Recognition as Key Diagnostic Cardiac Monitoring System by US and UK Health Organizations
SAN FRANCISCO, April 10, 2017 (GLOBE NEWSWIRE) — iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care solutions company focused on the advancement of cardiac care, announced the recent publication of two documents in support of extended continuous ambulatory monitoring for arrhythmia detection. The American College of Cardiology (ACC), the American […]



